492 A phase II, placebo-controlled study of merimepodib (XV-497), in combination with pegylated interferon-alfa, and ribavirin in patients with chronic hepatitis C non-responsive to previous therapy with interferon-alfa and ribavirin
- 31 December 2004
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 40, 145
- https://doi.org/10.1016/s0168-8278(04)90492-8
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: